Skip to main content
. 2021 Mar 29;14(1):616–621. doi: 10.1159/000513905

Fig. 1.

Fig. 1

History chart of ePROs as reported from the patient on her mobile device during treatment with vemurafenib. Blue, well-being; dark red, rash; light red, hand-foot syndrome; yellow, loss of appetite; olive green, nausea; orange, headache; green, cold symptoms; light purple, sensory disturbance; dark purple, gait disorder.